Pre-operative imaging in clinical International Federation of Gynecology and Obstetrics stage IB2 or less cervical carcinoma
- 6 February 2026
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (4) , 104562
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (P30CA008748)
This publication has 9 references indexed in Scilit:
- Financial Toxicity in Cancer Care: Implications for Clinical Care and Potential Practice SolutionsJournal of Clinical Oncology, 2023
- ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*International Journal of Gynecological Cancer, 2023
- Scanxiety among Adults with Cancer: A Scoping Review to Guide Research and InterventionsCancers, 2023
- Corrigendum to “Revised FIGO staging for carcinoma of the cervix uteri” [Int J Gynecol Obstet 145(2019) 129–135]International Journal of Gynecology & Obstetrics, 2019
- A Comprehensive Comparison of CT, MRI, Positron Emission Tomography or Positron Emission Tomography/CT, and Diffusion Weighted Imaging-MRI for Detecting the Lymph Nodes Metastases in Patients with Cervical Cancer: A Meta-Analysis Based on 67 StudiesGynecologic and Obstetric Investigation, 2017
- Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year updateJournal of Gynecologic Oncology, 2017
- 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancerAbdominal Radiology, 2014
- Preoperative staging of cervical cancer: Is 18-FDG-PET/CT really effective in patients with early stage disease?Gynecologic Oncology, 2011
- Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancerThe Lancet, 1997